Defunct Company
Total Trials
23
As Lead Sponsor
22
As Collaborator
1
Total Enrollment
3,159
NCT00597181
A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy
Phase: Phase 4
Role: Collaborator
Start: Nov 30, 2007
Completion: Aug 31, 2010
NCT01084525
OTO-104 for Meniere's Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2010
Completion: Apr 30, 2011
NCT01755286
OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement
Start: Dec 31, 2012
Completion: Jun 30, 2013
NCT01412177
OTO-104 for the Treatment of Meniere's Disease
Phase: Phase 2
Start: Nov 30, 2013
Completion: Apr 30, 2015
NCT01949142
OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement
Phase: Phase 3
Completion: Jun 30, 2014
NCT01949155
Completion: May 31, 2014
NCT02265393
A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom
Start: Oct 31, 2014
Completion: May 31, 2016
NCT02350998
Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration
Start: Jan 31, 2015
Completion: Mar 31, 2015
NCT02408796
Open-Label Study of OTO-201 for Treatment of AOMT
Start: Mar 31, 2015
Completion: May 31, 2015
NCT02511561
OTO-201 for the Treatment of Otitis Externa
Start: Jul 31, 2015
Completion: Nov 30, 2015
NCT02612337
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
Start: Oct 27, 2015
Completion: Jul 18, 2017
NCT02600559
Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes
Start: Oct 31, 2015
Completion: Jul 31, 2016
NCT02706730
A 6-Month Extension Study of OTO-104 in Meniere's Disease
Start: Feb 29, 2016
Completion: Sep 30, 2017
NCT02719158
Dose Ranging Study of OTO-201 in AOMT
NCT02717442
Start: Mar 21, 2016
Completion: Sep 15, 2017
NCT02740387
Open Label Study of OTO-104 in Subjects With Meniere's Disease
Start: Jun 30, 2016
NCT02801370
Phase 3 Study of OTO-201 in Acute Otitis Externa
Completion: Dec 31, 2016
NCT02768662
Start: Aug 31, 2016
NCT02997189
Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss
Start: Nov 15, 2016
Completion: Sep 26, 2017
NCT03664674
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
Start: Aug 27, 2018
Completion: Dec 22, 2020
NCT03918109
OTO-313 in Subjects With Subjective Tinnitus
Phase: Phase 1/2
Start: Apr 4, 2019
Completion: May 29, 2020
NCT04129775
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
Start: Oct 1, 2019
Completion: Sep 5, 2022
NCT04829214
OTO-313 in Subjects With Unilateral Subjective Tinnitus
Start: Mar 22, 2021
Completion: Jun 30, 2022